Back to results
US 2006/0068457 A1Published application
Substrates for tafi (a)
AssigneeDsm IP Assets B.V.
InventorsHugo Ziegler, Dagmar Prasa, Jorg Sturzebecher, Peter Wilkstroem
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds of general formula (I) and acid addition salts thereof, where the various symbols have the meanings given in the description and claims, the production and use thereof as substrate for the detection of TAFIa, a fibrinolysis inhibiting enzyme. The detection occurs by using the absorption between 400 and 412 nm, arising as a result of the formation of 3-carboxy-4-nitrothiophenol from Ellman's reagent as a function of time.
Claims19
Compounds of general formula I
- wherein
- R1 means a CH2NH2 or NHC(NH)NH2 group,
- AA2 means non-substituted or substituted lysine, ornithine, arginine or histidine, wherein the substituents are common protective groups,
- AA3 means a natural amino acid in which a present, protectable group may be substituted with a usual protective group in the side chain,
- n represents 0 or 1, and
- R2 means a Bz, Bzl, Ac, Boc, Z, Suc, MeoSuc or Tos group,
- provided that the following cases do not occur simultaneously:
- n=0, R1=NHC(NH)NH2, R2=Z and (AA2)=non-substituted or Boc-substituted lysine, as racemated or as enantiomeric pure isomers, and the salts thereof with mineral or organic acids.
5 more elements
(canceled)
Dependencies are inferred from the claim text.